CLINICAL_TRIALS
trial_result
· 2016-03-23
Clinical Trial Update: Liraglutide Efficacy and Action in Non-Alcoholic Steatohepatitis [Phase 2]
Summary
A Phase 2 trial evaluating liraglutide for nonalcoholic steatohepatitis has completed, with updates on its efficacy and mechanism of action.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Birmingham | Conditions: Nonalcoholic Steatohepatitis | Phase 2 | Status: COMPLETED